As momentum builds around the EU Biotech Act, this invitation-only 60 minute session will provide a focused presentation and discussion on its strategic importance for the biotech industry. The session will cover the progress of Part I and the ambitions for Part II, with a strong emphasis on how the Act will shape company strategy across sectors.
We warmly encourage SwedenBIO members to take advantage of this opportunity to gain insights and engage in strategic dialogue on one of the most important upcoming policy frameworks for the biotech sector.
This is an invitation-only event.
